[HTML][HTML] Genomic and epigenomic profile of thyroid cancer
A Acuña-Ruiz, C Carrasco-López… - Best Practice & Research …, 2023 - Elsevier
Thyroid cancer is the most common malignancy of the endocrine system, and its incidence
has been steadily increasing. Advances in sequencing have allowed analysis of the entire …
has been steadily increasing. Advances in sequencing have allowed analysis of the entire …
[HTML][HTML] Molecular mechanisms of thyroid cancer: a competing endogenous RNA (ceRNA) point of view
Y Liu, S Khan, L Li, TLM Ten Hagen… - Biomedicine & …, 2022 - Elsevier
Thyroid cancer (TC) is the most prevalent malignancy of the endocrine system. Although
there are few treatment choices for individuals with TC, determining the underlying …
there are few treatment choices for individuals with TC, determining the underlying …
[HTML][HTML] Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer
Cancer of the thyroid is the most common endocrine malignancy. While treatment options
are limited for individuals with medullary or anaplastic thyroid cancer, understanding the …
are limited for individuals with medullary or anaplastic thyroid cancer, understanding the …
[HTML][HTML] The lncRNA CASC2 modulates hepatocellular carcinoma cell sensitivity and resistance to TRAIL through apoptotic and non-apoptotic signaling
J Sun, H Xu, Z Lei, Z Li, H Zhu, Z Deng, X Yu… - Frontiers in …, 2022 - frontiersin.org
The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has
been widely concerned as a tumor therapy because of its ability of selective triggering …
been widely concerned as a tumor therapy because of its ability of selective triggering …
C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers
A Paszkowska, T Kolenda, K Guglas… - Journal of Personalized …, 2022 - mdpi.com
Long non-coding RNAs have proven to be important molecules in carcinogenesis. Due to
little knowledge about them, the molecular mechanisms of tumorigenesis are still being …
little knowledge about them, the molecular mechanisms of tumorigenesis are still being …
[HTML][HTML] The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression
L Xia, J Chen, M Huang, J Mei, M Lin - Frontiers in Oncology, 2022 - frontiersin.org
Accumulated evidence has revealed that F-box protein, a subunit of SCF E3 ubiquitin ligase
complexes, participates in carcinogenesis and tumor progression via targeting its substrates …
complexes, participates in carcinogenesis and tumor progression via targeting its substrates …
Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology
J Kozłowska-Masłoń, K Guglas, A Paszkowska… - Journal of Personalized …, 2022 - mdpi.com
Long non-coding RNAs (lncRNAs) consist of at least 200 nucleotides. Although these
molecules do not code proteins, they carry many regulatory functions in normal cells, as well …
molecules do not code proteins, they carry many regulatory functions in normal cells, as well …
Abnormal expression and clinical value analysis of long noncoding RNA cancer susceptibility candidate 2 in children with severe pneumonia complicated with …
J Ni, J Lu, D Lu - The Clinical Respiratory Journal, 2022 - Wiley Online Library
Objective Severe pneumonia occurs commonly in children and is the main cause of clinical
infant mortality. This study tested the expression pattern of long noncoding RNA cancer …
infant mortality. This study tested the expression pattern of long noncoding RNA cancer …
Progress in long non-coding RNAs as prognostic factors of papillary thyroid carcinoma
H Zhu, D Song, S Zhang, Z Zheng, X Chen… - Pathology-Research and …, 2024 - Elsevier
Papillary thyroid carcinoma (PTC) is generally recognized as a slow-growing tumor.
However, a small subset of patients may still experience relapse or metastasis shortly after …
However, a small subset of patients may still experience relapse or metastasis shortly after …
[HTML][HTML] Long non-coding RNA EGOT is associated with 131iodine sensitivity and contributes to thyroid cancer progression by targeting miR-641/PTEN axis
M Wang, Z Wei, S Wang, W Feng, L Shang… - Aging (Albany NY …, 2023 - ncbi.nlm.nih.gov
Thyroid cancer is a prevalent endocrine malignancy around the world. Radioactive 131
iodine (131 I) therapy is widely applied in TC patients, but the resistance affects its …
iodine (131 I) therapy is widely applied in TC patients, but the resistance affects its …